InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARROWHEAD PHARMACEUTICALS, INC.

ARWR Clue Score51
United States Fiscal year ends September CIK 0000879407 Results filed 4 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Michael S Perry
18 Aug 2026
Director
Sell
11,600
$87.30
$1.01M
Adeoye Y Olukotun
18 Aug 2026
Director
Sell
2,000
$86.96
$173.92K
Christopher Richard Anzalone
17 Dec 2025
Chief Executive Officer
Sell
1,981
$66.30
$131.34K
Christopher Richard Anzalone
17 Dec 2025
Chief Executive Officer
Sell
982
$65.53
$64.35K
Christopher Richard Anzalone
17 Dec 2025
Chief Executive Officer
Sell
35,750
$64.51
$2.31M
Christopher Richard Anzalone
17 Dec 2025
Chief Executive Officer
Sell
46,287
$63.55
$2.94M
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
3,221
$67.87
$218.61K
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
166
$66.77
$11.08K
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
1,300
$65.77
$85.50K
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
1,000
$64.96
$64.96K
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
6,661
$64.29
$428.24K
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
8,476
$62.94
$533.48K
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
14,095
$62.12
$875.58K
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
10,963
$61.25
$671.48K
Christopher Richard Anzalone
16 Dec 2025
Chief Executive Officer
Sell
8,416
$60.51
$509.25K
Christopher Richard Anzalone
15 Dec 2025
Chief Executive Officer
Sell
8,147
$69.96
$569.96K
Christopher Richard Anzalone
15 Dec 2025
Chief Executive Officer
Sell
21,321
$69.28
$1.48M
Christopher Richard Anzalone
15 Dec 2025
Chief Executive Officer
Sell
100,532
$68.67
$6.90M
Michael S Perry
5 Dec 2025
Director
Sell
16,250
$61.03
$991.74K
Mauro Ferrari
28 Nov 2025
Director
Sell
8,750
$56.39
$493.41K
Show all 64 transactions →

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 2
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 528,641
History held since 15 Nov 2006